The group B coxsackieviruses and myocarditis (Q34464947)

2 August 2017

1 reference

title

The group B coxsackieviruses and myocarditis (English)

1 reference

2 August 2017

Kim KS

1

1 reference

2 August 2017

Hufnagel G

series ordinal

2

1 reference

2 August 2017

Chapman NM

series ordinal

3

1 reference

2 August 2017

Tracy S

series ordinal

4

1 reference

2 August 2017

publication date

1 November 2001

1 reference

Reviews in Medical Virology

2 August 2017

published in

1 reference

2 August 2017

volume

11

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

355-368

1 reference

An Unidentified, Filtrable Agent Isolated From the Feces of Children With Paralysis

2 August 2017

cites work

1 reference

Bornholm disease in children.

21 January 2018

1 reference

Twenty year autopsy statistics of myocarditis incidence in Japan

21 January 2018

1 reference

Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop

21 January 2018

1 reference

Prevalence of overt dilated cardiomyopathy in two regions of England

21 January 2018

1 reference

Cardiomyopathy in western Denmark

21 January 2018

1 reference

Cardiac manifestations during a Coxsackie B5 epidemic

21 January 2018

1 reference

21 January 2018

Viruses and myocarditis

1 reference

Coxsackie B virus infections in new zealand patients with cardiac and non-cardiac diseases

21 January 2018

1 reference

Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases

21 January 2018

1 reference

Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy

21 January 2018

1 reference

Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult

21 January 2018

1 reference

Heart disease caused by Coxsackie virus B infection

21 January 2018

1 reference

Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

A molecular and serologic evaluation of enteroviral involvement in human myocarditis

21 January 2018

1 reference

Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes

21 January 2018

1 reference

Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice

21 January 2018

1 reference

Myocarditis: unresolved issues in diagnosis and treatment

21 January 2018

1 reference

Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction

21 January 2018

1 reference

Dilated Cardiomyopathy Associated With Hepatitis C Virus Infection

21 January 2018

1 reference

Hepatitis C virus infection and heart diseases: a multicenter study in Japan

21 January 2018

1 reference

Classification of enteroviruses based on molecular and biological properties

21 January 2018

1 reference

Purification of the putative coxsackievirus B receptor from HeLa cells

21 January 2018

1 reference

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

21 January 2018

1 reference

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

Receptor for the group B coxsackieviruses and adenoviruses: CAR

21 January 2018

1 reference

Autoimmunity in myocarditis: relevance of animal models

21 January 2018

1 reference

Coxsackieviruses and pancreatitis

21 January 2018

1 reference

21 January 2018

1 reference

Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report

21 January 2018

1 reference

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

21 January 2018

1 reference

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

21 January 2018

1 reference

Myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

Myocarditis, pericarditis and other pericardial diseases

21 January 2018

1 reference

Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease

21 January 2018

1 reference

History of Sabin attenuated poliovirus oral live vaccine strains

21 January 2018

1 reference

The biologic principles of poliovirus eradication

21 January 2018

1 reference

Poliomyelitis eradication

21 January 2018

1 reference

Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis.

21 January 2018

1 reference

A single amino acid substitution in the capsid protein VP1 of Coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model

21 January 2018

1 reference

Severity of disease induced by a pancreatropic Coxsackie B4 virus correlates with the H-2Kq locus of the major histocompatibility complex

21 January 2018

1 reference

The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae

21 January 2018

1 reference

Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain

21 January 2018

1 reference

Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.

21 January 2018

1 reference

Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E.

21 January 2018

1 reference

Molecular requirements for lineage commitment in the thymus--antibody-mediated receptor engagements reveal a central role for lck in lineage decisions

21 January 2018

1 reference

The Src kinase p56(lck) up-regulates VLA-4 integrin affinity. Implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin

21 January 2018

1 reference

Requirement of MIP-1 alpha for an inflammatory response to viral infection

21 January 2018

1 reference

Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus

21 January 2018

1 reference

Role of MIP-2 in coxsackievirus B3 myocarditis

21 January 2018

1 reference

Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection

21 January 2018

1 reference

T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes

21 January 2018

1 reference

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

21 January 2018

1 reference

An antiviral mechanism of nitric oxide: inhibition of a viral protease.

21 January 2018

1 reference

The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis

21 January 2018

1 reference

Expression of an antigenic adenovirus epitope in a group B coxsackievirus

21 January 2018

1 reference

A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice

21 January 2018

1 reference

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.326

1 reference

2 August 2017

1 reference